Unfortunately I won't be attending because of the travel distance involved. I was wondering if any HC members on this thread would be attending, if so could we have a collection of questions/concerns on this thread in which they would be willing to take to the meeting.
I have emailed MR re the progress of the patient/s administered the CVac treatment back in march 09. He has declined to respond to this question in his replies (understandably it would be market sensitive)
IMO It is pointless having a investor briefing if management are only going to repeat what has already been reported to the market re ASX announcements.
Therefore my question to take to the meeting would be: 1. How are the patients who are receiving the CVac treatment via the Australian Regulatory Control Mechanism’s Special Access Scheme under the TGA progressing?
Thanks in advance, boiler
PRR Price at posting:
5.9¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)